[1]
|
Bertsias, G.K., Pamfil, C., Fanouriakis, A. and Boumpas, D.T. (2013) Diagnostic Criteria for Systemic Lupus Erythe-matosus: Has the Time Come? Nature Reviews Rheumatology, 9, 687-694. https://doi.org/10.1038/nrrheum.2013.103
|
[2]
|
Stojan, G. and Petri, M. (2018) Epidemiology of Systemic Lupus Erythematosus: An Update. Current Opinion in Rheumatology, 30, 144-150. https://doi.org/10.1097/BOR.0000000000000480
|
[3]
|
Moulton, V.R., Suarez-Fueyo, A., Meidan, E., Li, H., Mizui, M. and Tsokos, G.C. (2017) Pathogenesis of Human Systemic Lupus Erythematosus: A Cellular Perspective. Trends in Molecular Medicine, 23, 615-635.
https://doi.org/10.1016/j.molmed.2017.05.006
|
[4]
|
Hannah, J.R. and D’Cruz, D.P. (2019) Pulmonary Complica-tions of Systemic Lupus Erythematosus. Seminars in Respiratory and Critical Care Medicine, 40, 227-234. https://doi.org/10.1055/s-0039-1685537
|
[5]
|
Çiftçi, E., Yalçinkaya, F., Ince, E., Ekim, M., Ileri, M., Örgerin, Z., Fitöz, S., Güriz, H., Aysev, A.D. and Dogru, Ü. (2004) Pulmonary Involvement in Childhood-Onset Systemic Lupus Erythematosus: A Report of Five Cases. Rheumatology, 43, 587-591. https://doi.org/10.1093/rheumatology/keh120
|
[6]
|
Rabinovich, C.E. (2012) Pulmonary Complications of Child-hood Rheumatic Disease. Paediatric Respiratory Reviews, 13, 29-36. https://doi.org/10.1016/j.prrv.2011.05.005
|
[7]
|
Tsokos, G.C. (2011) Systemic Lupus Erythematosus. The New England Journal of Medicine, 365, 2110-2121.
https://doi.org/10.1056/NEJMra1100359
|
[8]
|
Bertoli, A.M., Vila, L.M., Apte, M., Fessler, B.J., Bastian, H.M., Reveille, J.D. and Alarcon, G.S. (2007) Systemic Lupus Erythematosus in a Multiethnic US Cohort LUMINA XLVIII: Factors Predictive of Pulmonary Damage. Lupus, 16, 410-417. https://doi.org/10.1177/0961203307079042
|
[9]
|
Memet, B. and Ginzler, E.M. (2007) Pulmonary Manifestations of Systemic Lupus Erythematosus. Seminars in Respiratory and Critical Care Medicine, 28, 441-450. https://doi.org/10.1055/s-2007-985665
|
[10]
|
Kamen, D.L. and Strange, C. (2010) Pulmonary Manifestations of Systemic Lupus Erythematosus. Clinics in Chest Medicine, 31, 479-488. https://doi.org/10.1016/j.ccm.2010.05.001
|
[11]
|
Wallace, D.J. and Hahn, B. (2018) Dubois’ Lupus Erythematosus and Related Syndromes. 9th Edition, Elsevier, Edinburgh.
|
[12]
|
Lahita, R.G. (2010) Systemic Lupus Erythematosus. 5th Edition, Elsevier Academic Press, Amsterdam.
|
[13]
|
Fenlon, H.M., Doran, M., Sant, S.M. and Breatnach, E. (1996) High-Resolution Chest CT in Systemic Lupus Erythematosus. AJR American Journal of Roentgenology, 166, 301-307. https://doi.org/10.2214/ajr.166.2.8553934
|
[14]
|
Aguilera-Pickens, G. and Abud-Mendoza, C. (2018) Pulmonary Manifestations in Systemic Lupus Erythematosus: Pleural Involvement, Acute Pneumonitis, Chronic Interstitial Lung Disease and Diffuse Alveolar Hemorrhage. Reumatología Clínica, 14, 294-300. https://doi.org/10.1016/j.reumae.2018.03.001
|
[15]
|
Nakano, M., Hasegawa, H., Takada, T., Ito, S., Muramatsu, Y., Satoh, M., Suzuki, E. and Gejyo, F. (2002) Pulmonary Diffusion Capacity in Patients with Systemic Lupus Erythemato-sus. Respirology, 7, 45-49.
https://doi.org/10.1046/j.1440-1843.2002.00361.x
|
[16]
|
Keane, M.P. and Lynch, J.P. (2000) Pleuropulmonary Manifestations of Systemic Lupus Erythematosus. Thorax, 55, 159-166. https://doi.org/10.1136/thorax.55.2.159
|
[17]
|
Wang, L., Xiong, C., Li, M., Zeng, X., Wang, Q., Fang, W. and Zhao, L. (2020) Assessment of Lung Glucose Uptake in Patients with Systemic Lupus Erythematosus Pulmonary Arterial Hy-pertension: A Quantitative FDG-PET Imaging Study. Annals of Nuclear Medicine, 34, 407-414. https://doi.org/10.1007/s12149-020-01461-y
|
[18]
|
Crestani, B. (2005) The Respiratory System in Connective Tis-sue Disorders. Allergy, 60, 715-734.
https://doi.org/10.1111/j.1398-9995.2005.00761.x
|
[19]
|
Torre, O. and Harari, S. (2011) Pleural and Pulmonary In-volvement in Systemic Lupus Erythematosus. La Presse Médicale, 40, e41-e51. https://doi.org/10.1016/j.lpm.2010.11.004
|
[20]
|
Good, J.T., King, T.E., Antony, V.B. and Sahn, S.A. (1983) Lupus Pleuritis. Clinical Features and Pleural Fluid Characteristics with Special Reference to Pleural Fluid Antinuclear Antibod-ies. Chest, 84, 714-718.
https://doi.org/10.1378/chest.84.6.714
|
[21]
|
King, T.E., Kim, E.J. and Kinder, B.W. (2011) Connective Tissue Dis-eases. In: Schwartz, M.I. and King, T.E., Eds., Interstitial Lung Disease, 5th Edition, People’s Medical Publishing House, Shelton.
|
[22]
|
Sharma, S., Smith, R. and Al-Hameed, F. (2002) Fibrothorax and Severe Lung Restriction Secondary to Lupus Pleuritis and Its Successful Treatment by Pleurectomy. Canadian Respiratory Journal, 9, 335-337.
https://doi.org/10.1155/2002/740878
|
[23]
|
Wang, D.Y. (2002) Diagnosis and Management of Lupus Pleuritis. Current Opinion in Pulmonary Medicine, 8, 312-316.
https://doi.org/10.1097/00063198-200207000-00012
|
[24]
|
Breuer, G.S., Deeb, M., Fisher, D. and Nesher, G. (2005) Therapeutic Options for Refractory Massive Pleural Effusion in Systemic Lupus Erythematosus: A Case Study and Review of the Literature. Seminars in Arthritis and Rheumatism, 34, 744-749. https://doi.org/10.1016/j.semarthrit.2004.11.003
|
[25]
|
Meissner, M., Sherer, Y., Levy, Y., Chwalinska-Sadowska, H., Langevitz, P. and Shoenfeld, Y. (2000) Intravenous Immunoglobulin Therapy in a Patient with Lupus Serositis and Nephritis. Rheumatology International, 19, 199-201.
https://doi.org/10.1007/s002960000053
|
[26]
|
Sherer, Y., Langevitz, P., Levy, Y., Fabrizzi, F. and Shoenfeld, Y. (1999) Treatment of Chronic Bilateral Pleural Effusions with Intravenous Immunoglobulin and Cyclosporin. Lupus, 8, 324-327.
https://doi.org/10.1191/096120399678847759
|
[27]
|
Kim, S., Park, H.-B., Cho, Y.K., Yi, S., Oh, K., Kim, D.K. and Yoo, B. (2017) Refractory Pleural Effusion in Systemic Lupus Erythematosus Treated by Pleurectomy. Journal of Rheumatic Diseases, 24, 43-47.
https://doi.org/10.4078/jrd.2017.24.1.43
|
[28]
|
Aringer, M., Costenbader, K., Daikh, D., Brinks, R., Mosca, M., Ramsey-Goldman, R., Smolen, J.S., Wofsy, D., Boumpas, D.T., Kamen, D.L., et al. (2019) European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus. Arthritis & Rheumatology, 71, 1400-1412.
|
[29]
|
Karkhanis, V.S. and Joshi, J.M. (2012) Pleural Effusion: Diagnosis, Treatment, and Management. Open Access Emergency Medicine, 4, 31-52. https://doi.org/10.2147/OAEM.S29942
|
[30]
|
Gilleece, M.H., Evans, C.C. and Bucknall, R.C. (1988) Steroid Resistant Pleural Effusion in Systemic Lupus Erythematosus Treated with Tetracycline Pleurodesis. Annals of Rheumatic Diseases, 47, 1031-1032.
https://doi.org/10.1136/ard.47.12.1031
|
[31]
|
McKnight, K.M., Adair, N.E. and Agudelo, C.A. (1991) Successful Use of Tetracycline Pleurodesis to Treat Massive Pleural Effusion Secondary to Systemic Lupus Erythematosus. Arthritis & Rheumatology, 34, 1483-1484.
https://doi.org/10.1002/art.1780341121
|
[32]
|
Elborn, J.S., Conn, P. and Roberts, S.D. (1987) Refractory Massive Pleural Effusion in Systemic Lupus Erythematosus Treated by Pleurectomy. Annals of Rheumatic Diseases, 46, 77-80. https://doi.org/10.1136/ard.46.1.77
|
[33]
|
Wiedemann, H.P. and Matthay, R.A. (1992) Pulmonary Manifestations of Systemic Lupus Erythematosus. Journal of Thoracic Imaging, 7, 1-18. https://doi.org/10.1097/00005382-199203000-00003
|
[34]
|
Matthay, R.A., Schwarz, M.I., Petty, T.L., Stanford, R.E., Gupta, R.C., Sahn, S.A. and Steigerwald, J.C. (1975) Pulmonary Manifestations of Systemic Lupus Erythematosus: Review of Twelve Cases of Acute Lupus Pneumonitis. Medicine, 54, 397-409. https://doi.org/10.1097/00005792-197509000-00003
|
[35]
|
Haupt, H.M., Moore, G.W. and Hutchins, G.M. (1981) The Lung in Systemic Lupus Erythematosus. Analysis of the Pathologic Changes in 120 Patients. The American Journal of Medicine, 71, 791-798.
https://doi.org/10.1016/0002-9343(81)90366-1
|
[36]
|
Swigris, J.J., Fischer, A., Gillis, J., Meehan, R.T. and Brown, K.K. (2008) Pulmonary and Thrombotic Manifestations of Systemic Lupus Erythematosus. Chest, 133, 271-280. https://doi.org/10.1378/chest.07-0079
|
[37]
|
Gutsche, M., Rosen, G.D. and Swigris, J.J. (2012) Connective Tissue Disease-Associated Interstitial Lung Disease: A Review. Current Respiratory Care Reports, 1, 224-232. https://doi.org/10.1007/s13665-012-0028-7
|
[38]
|
Winslow, W.A., Ploss, L.N. and Loitman, B. (1958) Pleuritis in Systemic Lupus Erythmatosus: Importance as an Early Manifestation in Diagnosis. Annals of Internal Medicine, 49, 70-88. https://doi.org/10.7326/0003-4819-49-1-70
|
[39]
|
Todd, D.J. and Costenbader, K.H. (2009) Dyspnoea in a Young Woman with Active Systemic Lupus Erythematosus. Lupus, 18, 777-784. https://doi.org/10.1177/0961203309104860
|
[40]
|
Cervera, R., Khamashta, M.A., Font, J., Sebastiani, G.D., Gil, A., Lavilla, P., Aydintug, A.O., Jedryka-Goral, A., de Ramon, E., Fernandez-Nebro, A., et al. (1999) Morbidity and Mortal-ity in Systemic Lupus Erythematosus during a 5-Year Period. A Multicenter Prospective Study of 1000 Patients. Euro-pean Working Party on Systemic Lupus Erythematosus. Medicine, 78, 167-175. https://doi.org/10.1097/00005792-199905000-00003
|
[41]
|
Al-Adhoubi, N.K. and Bystrom, J. (2020) Systemic Lupus Erythematosus and Diffuse Alveolar Hemorrhage, Etiology and Novel Treatment Strategies. Lupus, 29, 355-363. https://doi.org/10.1177/0961203320903798
|
[42]
|
Amarnani, R., Yeoh, S.A., Denneny, E.K. and Wincup, C. (2020) Lupus and the Lungs: The Assessment and Management of Pulmonary Manifestations of Systemic Lupus Erythematosus. Frontiers in Medicine, 7, Article ID: 610257.
https://doi.org/10.3389/fmed.2020.610257
|
[43]
|
Barile, L.A., Jara, L.J., Medina-Rodriguez, F., Garcia-Figueroa, J.L. and Miranda-Limon, J.M. (1997) Pulmonary Hemorrhage in Systemic Lupus Erythematosus. Lupus, 6, 445-448. https://doi.org/10.1177/096120339700600506
|
[44]
|
Martínez-Martínez, M.U. and Abud-Mendoza, C. (2014) Dif-fuse Alveolar Hemorrhage in Patients with Systemic Lupus Erythematosus. Clinical Manifestations, Treatment, and Prognosis. Reumatología Clínica, 10, 248-253.
https://doi.org/10.1016/j.reumae.2014.02.003
|
[45]
|
Finucci Curi, P., Pierrestegui, M., Ortiz, A., Ceccato, F. and Paira, S. (2015) Pulmonary Hemorrhage in Patients with Systemic Lupus Erythematosus. Clinical Manifestations and Prognosis. Medicina Clínica, 145, 375-379.
https://doi.org/10.1016/j.medcle.2014.07.010
|
[46]
|
Shen, M., Zeng, X., Tian, X., Zhang, F., Zeng, X., Zhang, X. and Xu, W. (2010) Diffuse Alveolar Hemorrhage in Systemic Lupus Erythematosus: A Retrospective Study in China. Lupus, 19, 1326-1330.
https://doi.org/10.1177/0961203310373106
|
[47]
|
Rojas-Serrano, J., Pedroza, J., Regalado, J., Robledo, J., Reyes, E., Sifuentes-Osornio, J. and Flores-Suarez, L.F. (2008) High Prevalence of Infections in Patients with Systemic Lupus Erythematosus and Pulmonary Haemorrhage. Lupus, 17, 295-299. https://doi.org/10.1177/0961203307086930
|
[48]
|
Shi, D., Wang, D., Li, X., Zhang, H., Che, N., Lu, Z. and Sun, L. (2012) Allogeneic Transplantation of Umbilical Cord-Derived Mesenchymal Stem Cells for Diffuse Alveolar Hemor-rhage in Systemic Lupus Erythematosus. Clinical Rheumatology, 31, 841-846. https://doi.org/10.1007/s10067-012-1943-2
|
[49]
|
Liu, G.-Y., Yang, H.-J., Tong, S.-Q., Li, Y.-J., Guo, A.-R. and Pang, H.-W. (2011) Value of Bronchoalveolar Lavage as a Rescue Measurement for Systemic Lupus Erythematosus Complicated with Diffuse Alveolar Hemorrhage. Chinese Medical Journal, 91, 1917-1919.
|
[50]
|
Weinrib, L., Sharma, O.P. and Quismorio, F.P. (1990) A Long-Term Study of Interstitial Lung Disease in Systemic Lupus Erythematosus. Seminars in Arthritis and Rheumatism, 20, 48-56.
https://doi.org/10.1016/0049-0172(90)90094-V
|
[51]
|
Tansey, D., Wells, A.U., Colby, T.V., Ip, S., Nikolakoupolou, A., Du Bois, R.M., Hansell, D.M. and Nicholson, A.G. (2004) Variations in Histological Patterns of Interstitial Pneu-monia between Connective Tissue Disorders and Their Relationship to Prognosis. Histopathology, 44, 585-596. https://doi.org/10.1111/j.1365-2559.2004.01896.x
|
[52]
|
Pope, J. (2008) An Update in Pulmonary Hypertension in Systemic Lupus Erythematosus—Do We Need to Know about It? Lupus, 17, 274-277. https://doi.org/10.1177/0961203307087188
|
[53]
|
Robles-Perez, A. and Molina-Molina, M. (2015) Treatment Con-siderations of Lung Involvement in Rheumatologic Disease. Respiration, 90, 265-274. https://doi.org/10.1159/000441238
|
[54]
|
Branger, S., Schleinitz, N., Gayet, S., Veit, V., Kaplanski, G., Badier, M., Magnan, A. and Harlé, J.R. (2004) Le syndrome des poumons rétractés et les maladies auto-immunes. La Revue de Mé-decine Interne, 25, 83-90.
https://doi.org/10.1016/j.revmed.2003.09.010
|
[55]
|
Karim, M.Y., Miranda, L.C., Tench, C.M., Gordon, P.A., D’Cruz, D.P., Khamashta, M.A. and Hughes, G.R. (2002) Presentation and Prognosis of the Shrinking Lung Syndrome in Systemic Lupus Erythematosus. Seminars in Arthritis and Rheumatism, 31, 289-298. https://doi.org/10.1053/sarh.2002.32555
|
[56]
|
Duron, L., Cohen-Aubart, F., Diot, E., Borie, R., Abad, S., Richez, C., Banse, C., Vittecoq, O., Saadoun, D., Haroche, J., et al. (2016) Shrinking Lung Syndrome Associated with Systemic Lupus Erythematosus: A Multicenter Collaborative Study of 15 New Cases and a Review of the 155 Cases in the Litera-ture Focusing on Treatment Response and Long-Term Outcomes. Autoimmunity Reviews, 15, 994-1000. https://doi.org/10.1016/j.autrev.2016.07.021
|
[57]
|
Hoffbrand, B.I. and Beck, E.R. (1965) “Unexplained” Dyspnoea and Shrinking Lungs in Systemic Lupus Erythematosus. British Medical Journal, 1, 1273-1277. https://doi.org/10.1136/bmj.1.5445.1273
|
[58]
|
Allen, D., Fischer, A., Bshouty, Z., Robinson, D.B., Peschken, C.A., Hitchon, C., El-Gabalawy, H., Meyers, M. and Mittoo, S. (2012) Evaluating Systemic Lupus Erythematosus Patients for Lung Involvement. Lupus, 21, 1316-1325.
https://doi.org/10.1177/0961203312454343
|
[59]
|
Borrell, H., Narvaez, J., Alegre, J.J., Castellvi, I., Mitjavila, F., Aparicio, M., Armengol, E., Molina-Molina, M. and Nolla, J.M. (2016) Shrinking Lung Syndrome in Systemic Lupus Erythematosus: A Case Series and Review of the Literature. Medicine, 95, e4626. https://doi.org/10.1097/MD.0000000000004626
|
[60]
|
Langenskiöld, E., Bonetti, A., Fitting, J.W., Heinzer, R., Dudler, J., Spertini, F. and Lazor, R. (2012) Shrinking Lung Syndrome Successfully Treated with Rituximab and Cyclo-phosphamide. Respiration, 84, 144-149.
https://doi.org/10.1159/000334947
|
[61]
|
Van Veen, S., Peeters, A.J., Sterk, P.J. and Breedveld, F.C. (1993) The “Shrinking Lung Syndrome” in SLE, Treatment with Theophylline. Clinical Rheumatology, 12, 462-465. https://doi.org/10.1007/BF02231771
|
[62]
|
Muñoz-Rodríguez, F., Font, J., Badia, J., Miret, C., Barberà, J., Cervera, R. and Ingelmo, M. (1997) Shrinking Lungs Syndrome in Systemic Lupus Erythematosus: Improvement with Inhaled Beta-Agonist Therapy. Lupus, 6, 412-414.
https://doi.org/10.1177/096120339700600413
|
[63]
|
Guleria, V.S., Singh, P.K., Saxena, P. and Subramanian, S. (2014) Shrinking Lung Syndrome in Systemic Lupus Erythematosus-Scleroderma Overlap. Lung India, 31, 407-409. https://doi.org/10.4103/0970-2113.142152
|
[64]
|
Benham, H., Garske, L., Vecchio, P. and Eckert, B.W. (2010) Successful Treatment of Shrinking Lung Syndrome with Rituximab in a Patient with Systemic Lupus Erythematosus. Journal of Clinical Rheumatology, 16, 68-70.
https://doi.org/10.1097/RHU.0b013e3181d0757f
|
[65]
|
Penacoba Toribio, P., Corica Albani, M.E., Mayos Perez, M. and Rodriguez de la Serna, A. (2014) Rituximab in the Treatment of Shrinking Lung Syndrome in Systemic Lupus Ery-thematosus. Reumatología Clínica, 10, 325-327.
https://doi.org/10.1016/j.reumae.2013.09.003
|
[66]
|
Robles-Perez, A., Dorca, J., Castellvi, I., Nolla, J.M., Moli-na-Molina, M. and Narvaez, J. (2020) Rituximab Effect in Severe Progressive Connective Tissue Disease-Related Lung Disease: Preliminary Data. Rheumatology International, 40, 719-726. https://doi.org/10.1007/s00296-020-04545-0
|
[67]
|
Reyes, F. and Lazaro, D. (2016) Systemic Lupus Erythematosus Complicated by Shrinking Lung Syndrome Treated with Belimumab: A Case Report. Chest, 150, 300A. https://doi.org/10.1016/j.chest.2016.08.313
|
[68]
|
Shah, S.J. (2012) Pulmonary Hypertension. JAMA, 308, 1366-1374. https://doi.org/10.1001/jama.2012.12347
|
[69]
|
Chen, H.A., Hsu, T.C., Yang, S.C., Weng, C.T., Wu, C.H., Sun, C.Y. and Lin, C.Y. (2019) Incidence and Survival Impact of Pulmonary Arterial Hypertension among Patients with Systemic Lupus Erythematosus: A Nationwide Cohort Study. Arthritis Research & Therapy, 21, 82. https://doi.org/10.1186/s13075-019-1868-0
|
[70]
|
Xu, S.Z., Yan, L., Li, X.P., Li, X.M., Shuai, Z.W., Leng, R.X., Pan, H.F. and Ye, D.Q. (2018) Features Associated with Pulmonary Arterial Hypertension in Chinese Hospitalized Sys-temic Lupus Erythematosus Patients. Clinical Rheumatology, 37, 1547-1553. https://doi.org/10.1007/s10067-018-4056-8
|
[71]
|
Hachulla, E., Jais, X., Cinquetti, G., Clerson, P., Rottat, L., Launay, D., Cottin, V., Habib, G., Prevot, G., Chabanne, C., et al. (2018) Pulmonary Arterial Hypertension Associated with Systemic Lupus Erythematosus: Results from the French Pulmonary Hypertension Registry. Chest, 153, 143-151. https://doi.org/10.1016/j.chest.2017.08.014
|
[72]
|
Lian, F., Chen, D., Wang, Y., Ye, Y., Wang, X., Zhan, Z., Xu, H., Liang, L. and Yang, X. (2012) Clinical Features and Independent Predictors of Pulmonary Arterial Hypertension in Sys-temic Lupus Erythematosus. Rheumatology International, 32, 1727-1731. https://doi.org/10.1007/s00296-011-1880-4
|
[73]
|
Li, J., Leng, X., Li, Z., Ye, Z., Li, C., Li, X., Zhu, P., Wang, Z., Zheng, Y. and Li, X. (2014) Chinese SLE Treatment and Research Group Registry: III. Association of Autoantibodies with Clinical Manifestations in Chinese Patients with Systemic Lupus Erythematosus. Journal of Immunology Research, 2014, Article ID: 809389.
https://doi.org/10.1155/2014/809389
|
[74]
|
Gonzalez-Lopez, L., Cardona-Muñoz, E.G., Celis, A., García-de la Torre, I., Orozco-Barocio, G., Salazar-Paramo, M., GarciaGonzalez, C., Garcia-Gonzalez, A., Sanchez-Ortiz, A., Trujil-lo-Hernandez, B., et al. (2004) Therapy with Intermittent Pulse Cyclophosphamide for Pulmonary Hypertension Associ-ated with Systemic Lupus Erythematosus. Lupus, 13, 105-112. https://doi.org/10.1191/0961203304lu509oa
|
[75]
|
Sanchez, O., Sitbon, O., Jais, X., Simonneau, G. and Humbert, M. (2006) Immunosuppressive Therapy in Connective Tissue Diseases-Associated Pulmonary Arterial Hypertension. Chest, 130, 182-189.
https://doi.org/10.1378/chest.130.1.182
|
[76]
|
Miyamichi-Yamamoto, S., Fukumoto, Y., Sugimura, K., Ishii, T., Satoh, K., Miura, Y., Tatebe, S., Nochioka, K., Aoki, T., Do, E.Z., et al. (2011) Intensive Immunosuppressive Therapy Improves Pulmonary Hemodynamics and Long-Term Prognosis in Patients with Pulmonary Arterial Hypertension As-sociated with Connective Tissue Disease. Circulation Journal, 75, 2668-2674. https://doi.org/10.1253/circj.CJ-11-0473
|
[77]
|
Kommireddy, S., Bhyravavajhala, S., Kurimeti, K., Chennareddy, S., Kanchinadham, S., Rajendra Vara Prasad, I. and Rajasekhar, L. (2015) Pulmonary Arterial Hypertension in Systemic Lupus Erythematosus May Benefit by Addition of Immunosuppression to Vasodilator Therapy: An Observational Study. Rheumatology, 54, 1673-1679.
https://doi.org/10.1093/rheumatology/kev097
|
[78]
|
Aviña-Zubieta, J.A., Lacaille, D., Sayre, E.C., Kopec, J., Choi, H.K. and Esdaile, J.M. (2012) Risk of Pulmonary Embolism and Deep Vein Thrombosis in Systemic Lupus Erythema-tosus: A Population-Based Cohort Study. Arthritis Research & Therapy, 14, A53. https://doi.org/10.1186/ar3987
|
[79]
|
You, H., Zhao, J., Wang, Q., Tian, X., Li, M. and Zeng, X. (2020) Characteris-tics and Risk Factors of Pulmonary Embolism in Patients with Systemic Lupus Erythematosus: A Case Control Study. Clinical and Experimental Rheumatology, 38, 940-948. https://doi.org/10.1136/lupus-2020-eurolupus.39
|
[80]
|
Smith, S.B., Geske, J.B., Maguire, J.M., Zane, N.A., Carter, R.E. and Morgenthaler, T.I. (2010) Early Anticoagulation Is Associated with Reduced Mortality for Acute Pulmonary Embolism. Chest, 137, 1382-1390.
https://doi.org/10.1378/chest.09-0959
|
[81]
|
Kearon, C., Akl, E.A., Ornelas, J., Blaivas, A., Jimenez, D., Bounameaux, H., Huisman, M., King, C.S., Morris, T.A., Sood, N., et al. (2016) Antithrombotic Therapy for VTE Dis-ease: CHEST Guideline and Expert Panel Report. Chest, 149, 315-352. https://doi.org/10.1016/j.chest.2015.11.026
|
[82]
|
Meyer, G., Vieillard-Baron, A. and Planquette, B. (2016) Recent Advances in the Management of Pulmonary Embolism: Focus on the Critically Ill Patients. Annals of Intensive Care, 6, 19. https://doi.org/10.1186/s13613-016-0122-z
|
[83]
|
Orens, J.B., Martinez, F.J. and Lynch, J.P. (1994) Pleuropul-monary Manifestations of Systemic Lupus Erythematosus. Rheumatic Disease Clinics of North America, 20, 159-193. https://doi.org/10.1016/S0889-857X(21)00230-1
|
[84]
|
Skeoch, S., Weatherley, N., Swift, A.J., Oldroyd, A., Johns, C., Hayton, C., Giollo, A., Wild, J.M., Waterton, J.C., Buch, M., et al. (2018) Drug-Induced Interstitial Lung Disease: A Systematic Review. Journal of Clinical Medicine, 7, 356. https://doi.org/10.3390/jcm7100356
|
[85]
|
Spagnolo, P., Bonniaud, P., Rossi, G., Sverzellati, N. and Cottin, V. (2022) Drug-Induced Interstitial Lung Disease. European Respir-atory Journal, 60, Article ID: 2102776. https://doi.org/10.1183/13993003.02776-2021
|